Low dopamine D2 receptor binding in subregions of the thalamus in schizophrenia

被引:85
|
作者
Yasuno, F
Suhara, T
Okubo, Y
Sudo, Y
Inoue, M
Ichimiya, T
Takano, A
Nakayama, K
Haildin, C
Farde, L
机构
[1] Natl Inst Radiol Sci, Brain Imaging Project, Inage Ku, Chiba 2638555, Japan
[2] Tokyo Med & Dent Univ, Biofunct Informat, Grad Sch Allied Hlth Sci, Tokyo, Japan
[3] Jikei Univ, Dept Psychiat, Sch Med, Tokyo, Japan
[4] Karolinska Inst, Dept Clin & Neurosci, Psychiat Sect, Stockholm, Sweden
来源
AMERICAN JOURNAL OF PSYCHIATRY | 2004年 / 161卷 / 06期
关键词
D O I
10.1176/appi.ajp.161.6.1016
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: Several structural and functional brain imaging studies have pointed to a disturbance of thalamic subnuclei in patients with schizophrenia. The dopamine hypothesis of schizophrenia has, however, not been thoroughly examined in terms of this complex structure, which has connections with most brain regions of central interest in schizophrenia research. The aim of the present study was to examine dopamine D-2 receptor binding in subregions of the thalamus in patients with schizophrenia. Method: The authors used positron emission tomography and the radioligand [C-11]FLB457 to examine dopamine D-2 receptor binding in thalamic subregions of 10 drug-naive patients with schizophrenia. Binding potential was calculated by the reference tissue method and used as an index for dopamine D-2 receptor binding. Comparisons were made with 19 healthy subjects. Subregions of interest were de-fined on individual magnetic resonance images using a percentage-based operational approach. Clinical symptoms were rated by using the Brief Psychiatric Rating Scale (BPRS). Results: The [C-11]FLB457 binding potential was lower in the central medial and posterior subregions of the thalamus in patients with schizophrenia. At a functional level, there was a significant negative correlation between binding potential and BPRS positive symptom scores. Conclusions: The subregions with low D-2 receptor binding comprise primarily the dorsomedial nucleus and pulvinar, two important components in circuitries previously suggested in the pathophysiology of schizophrenia. Aberrant dopaminergic neurotransmission in thalamic subregions might be a mechanism underlying positive symptoms in schizophrenia.
引用
收藏
页码:1016 / 1022
页数:7
相关论文
共 50 条
  • [31] Introversion, neuroticism, and the dopamine D2 receptor gene in schizophrenia.
    Alfimova, MV
    Golimbet, VE
    Aksenova, MG
    Ovchinnikov, IA
    Savina, TD
    Abramova, LI
    Kaleda, VG
    Braga, EA
    Pekarsky, LI
    Serebrennikova, IE
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1997, 74 (06): : 622 - 622
  • [32] The past, present and future role of the dopamine D2 receptor in schizophrenia
    Kapur, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S163 - S164
  • [33] NO LINKAGE BETWEEN D2 DOPAMINE RECEPTOR GENE REGION AND SCHIZOPHRENIA
    MOISES, HW
    GELERNTER, J
    GIUFFRA, LA
    ZARCONE, V
    WETTERBERG, L
    CIVELLI, O
    KIDD, KK
    CAVALLISFORZA, LL
    GRANDY, DK
    KENNEDY, JL
    VINOGRADOV, S
    MAUER, J
    LITT, M
    SJOGREN, B
    ARCHIVES OF GENERAL PSYCHIATRY, 1991, 48 (07) : 643 - 647
  • [34] Evidence that calmodulin binding to the dopamine D2 receptor enhances receptor signaling
    Liu, Yong
    Buck, David C.
    Macey, Tara A.
    Lan, Hongxiang
    Neve, Kim A.
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2007, 27 (01) : 47 - 65
  • [35] Low methylation rates of dopamine receptor D2 gene promoter sites in Japanese schizophrenia subjects
    Yoshino, Yuta
    Kawabe, Kentaro
    Mori, Takaaki
    Mori, Yoko
    Yamazaki, Kiyohiro
    Numata, Shusuke
    Nakata, Shunsuke
    Yoshida, Taku
    Iga, Jun-ichi
    Ohmori, Tetsuro
    Ueno, Shu-ichi
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2016, 17 (06): : 449 - 456
  • [36] Interaction analysis of apolipoprotein D and dopamine D2 receptor gene variants in schizophrenia
    Almos, P. Z.
    Horvath, S.
    Juhasz, A.
    Janka, Z.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S456 - S457
  • [37] Dopamine Synthesis Capacity is Associated with D2/3 Receptor Binding but Not Dopamine Release
    Berry, Anne S.
    Shah, Vyoma D.
    Furman, Daniella J.
    White, Robert L., III
    Baker, Suzanne L.
    O'Neil, James P.
    Janabi, Mustafa
    D'Esposito, Mark
    Jagust, William J.
    NEUROPSYCHOPHARMACOLOGY, 2018, 43 (06) : 1201 - 1211
  • [38] Effects of dopamine on the in vivo binding of dopamine D2 receptor radioligands in rat striatum
    Moresco, RM
    Loc'h, C
    Ottaviani, M
    Guibert, B
    Leviel, V
    Maziere, M
    Fazio, F
    Maziere, B
    NUCLEAR MEDICINE AND BIOLOGY, 1999, 26 (01) : 91 - 98
  • [39] Dopamine Synthesis Capacity is Associated with D2/3 Receptor Binding but Not Dopamine Release
    Anne S Berry
    Vyoma D Shah
    Daniella J Furman
    Robert L White III
    Suzanne L Baker
    James P O’Neil
    Mustafa Janabi
    Mark D’Esposito
    William J Jagust
    Neuropsychopharmacology, 2018, 43 : 1201 - 1211
  • [40] Dopamine D2 receptor gene polymorphisms and clinical response to dopamine D2 receptor antagonists
    Mihara, K
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2002, 17 : S59 - S59